Biotech / Pharma
Estuary Biotherapeutics
Biotech / Pharma
Estuary Biotherapeutics, which develops genetic therapies for people with kidney diseases, launched with $103 million, including a $93 million Series A led by RA Capital Management and a $10 million seed round led by 4BIO Capital and GV.
Founded
Region
Investors
People